A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients, involving researchers from the University of Liverpool, has been launched. The PHOSP-COVID study has been awarded £8.4million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). This study is one of a number of COVID-19 studies that have been given urgent public health research status by the Department of Health and Social Care.
Led by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, the PHOSP-COVID study will draw on expertise from a consortium of leading researchers, and clinicians from across the UK to assess the impact of COVID-19 on patient health and their recovery. Researchers from the University of Liverpool are members of this consortium.
ISARIC’s members Kenneth Baillie, Calum Semple are collaborating with Peter Openshaw on this study, hoping to gain a better understanding of long-term health impacts of COVID-19.
